447 related articles for article (PubMed ID: 18706702)
1. Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
Davison LJ; Weenink SM; Christie MR; Herrtage ME; Catchpole B
Vet Immunol Immunopathol; 2008 Nov; 126(1-2):83-90. PubMed ID: 18706702
[TBL] [Abstract][Full Text] [Related]
2. Autoantigens in insulin-dependent diabetes mellitus: molecular cloning and characterization of human IA-2 beta.
Li Q; Borovitskaya AE; DeSilva MG; Wasserfall C; Maclaren NK; Notkins AL; Lan MS
Proc Assoc Am Physicians; 1997 Jul; 109(4):429-39. PubMed ID: 9220540
[TBL] [Abstract][Full Text] [Related]
3. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation with human recombinant autoantigens.
Lernmark A; Agardh CD
Trends Immunol; 2005 Nov; 26(11):608-12. PubMed ID: 16153889
[TBL] [Abstract][Full Text] [Related]
5. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
[TBL] [Abstract][Full Text] [Related]
6. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase.
Syren K; Lindsay L; Stoehrer B; Jury K; Lühder F; Baekkeskov S; Richter W
J Immunol; 1996 Dec; 157(11):5208-14. PubMed ID: 8943434
[TBL] [Abstract][Full Text] [Related]
7. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.
Chen S; Willis J; Maclean C; Ananieva-Jordanova R; Amoroso MA; Brooking H; Powell M; Collins A; Bennett S; Mitchell S; Burne P; Furmaniak J; Smith BR
Clin Chim Acta; 2005 Jul; 357(1):74-83. PubMed ID: 15963796
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune diabetes in adults: lessons from the UKPDS.
Desai M; Clark A
Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976
[TBL] [Abstract][Full Text] [Related]
10. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
Reinsch B; Zimmy S; Schatz H; Pfohl M
Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
[TBL] [Abstract][Full Text] [Related]
11. Radiobinding assay for detecting autoantibodies to single epitopes.
Lampasona V; Belloni C; Piquer S; Bonicchio S; Furlan R; Bonifacio E
J Immunol Methods; 2008 Jul; 336(2):127-34. PubMed ID: 18501377
[TBL] [Abstract][Full Text] [Related]
12. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes.
Narendran P; Williams AJ; Elsegood K; Leech NJ; Dayan CM
Diabetes Metab Res Rev; 2003; 19(1):52-9. PubMed ID: 12592644
[TBL] [Abstract][Full Text] [Related]
13. GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient.
Schloot NC; Batstra MC; Duinkerken G; De Vries RR; Dyrberg T; Chaudhuri A; Behan PO; Roep BO
J Autoimmun; 1999 Jun; 12(4):289-96. PubMed ID: 10330300
[TBL] [Abstract][Full Text] [Related]
14. Higher FoxP3 mRNA expression in peripheral blood mononuclear cells of GAD65 or IA-2 autoantibody-positive compared with autoantibody-negative persons.
Link M; Salur L; Kisand K; Rajasalu T; Tillmann V; Uibo R
APMIS; 2008 Oct; 116(10):896-902. PubMed ID: 19132983
[TBL] [Abstract][Full Text] [Related]
15. High-titer GAD65 autoantibodies detected in adult diabetes patients using a high efficiency expression vector and cold GAD65 displacement.
Hansson I; Lynch KF; Hallmans G; Lernmark Å; Rolandsson O
Autoimmunity; 2011 Mar; 44(2):129-36. PubMed ID: 20670115
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
Römkens TE; Kusters GC; Netea MG; Netten PM
Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158
[TBL] [Abstract][Full Text] [Related]
17. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus.
Lan MS; Wasserfall C; Maclaren NK; Notkins AL
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6367-70. PubMed ID: 8692821
[TBL] [Abstract][Full Text] [Related]
18. Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus.
Tsirogianni A; Pipi E; Soufleros K
Autoimmun Rev; 2009 Jul; 8(8):687-91. PubMed ID: 19217947
[TBL] [Abstract][Full Text] [Related]
19. [Autoimmunity and glutamate decarboxylase antibodies in the pathogenesis of type I diabetes mellitus in experimental and clinical practice].
Kucera P; Andĕl M; Treslová L
Vnitr Lek; 1996 May; 42(5):359-67. PubMed ID: 8768297
[TBL] [Abstract][Full Text] [Related]
20. Genomic structure and promoter sequence of the insulin-dependent diabetes mellitus autoantigen, IA-2 (PTPRN).
Xie J; Zhang B; Lan MS; Notkins AL
Genomics; 1998 Dec; 54(2):338-43. PubMed ID: 9828138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
